Statement: Every patient in the primary trial is given tipifarnib PO, along with paclitaxel, doxorubicin hydrochloride and acyclophosphamide IV, but only a subset of participants undergo axillary lymph node dissection.
Primary_evidence: INTERVENTION 1:    Arm I   See Detailed Description   tipifarnib: Given orally   paclitaxel: Given IV   doxorubicin hydrochloride: Given IV   cyclophosphamide: Given IV   pegfilgrastim: Given SC   conventional surgery: surgical procedures performed on patients   axillary lymph node dissection: correlative study